RNAi in primary human chondrocytes: efficiencies, kinetics, and non-specific effects of siRNA-mediated gene suppression

Biologicals. 2007 Oct;35(4):321-8. doi: 10.1016/j.biologicals.2006.12.003. Epub 2007 Mar 23.

Abstract

RNAi-mediated gene silencing is a recent, powerful tool to investigate gene function. Controlling for experimental factors such as transfection efficiencies, siRNA concentration, gene suppression levels, gene suppression kinetics, or non-specific effects is key to robust results. In this methods paper, we compare the efficiencies of different transfection reagents in primary human chondrocytes (PHCs). We investigated TAK1 gene suppression efficiencies and kinetics on the mRNA and protein level depending on the siRNA concentration used. Furthermore, we evaluated PKR, IL-6, and TNF-alpha induction, as well as IkappaB degradation and NFkappaB activation as control parameters of non-specific siRNA effects. PKR and IL-6 proved to be appropriate markers of cellular inflammatory responses resulting from siRNA transfection. In addition, we compared different siRNAs (silencing, non-silencing, classic 21-mer, and 25-mer stealth siRNA) with respect to their capacity to induce cellular inflammatory responses. We found the occurrence of cellular responses in PHCs to be a function of the specific siRNA sequence in use. Hence, it is essential to analyze and to compare gene silencing siRNAs and control siRNAs with respect to their off-target effects prior to any functional gene validation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Cells, Cultured
  • Chondrocytes / immunology
  • Chondrocytes / metabolism*
  • Gene Expression
  • Humans
  • I-kappa B Proteins / metabolism
  • Interleukin-6 / biosynthesis
  • Kinetics
  • MAP Kinase Kinase Kinases / genetics
  • MAP Kinase Kinase Kinases / metabolism
  • NF-kappa B / metabolism
  • RNA Interference*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / genetics*
  • Transfection
  • Tumor Necrosis Factor-alpha / biosynthesis
  • eIF-2 Kinase / biosynthesis

Substances

  • I-kappa B Proteins
  • IL6 protein, human
  • Interleukin-6
  • NF-kappa B
  • RNA, Messenger
  • RNA, Small Interfering
  • TNF protein, human
  • Tumor Necrosis Factor-alpha
  • eIF-2 Kinase
  • MAP Kinase Kinase Kinases
  • MAP kinase kinase kinase 7